OSR Health (OSRHW) Other Non-Current Liabilities (2023 - 2026)
OSR Health (OSRHW) posted Other Non-Current Liabilities of $66539.0 for Q1 2026, up 3820.98% sequentially from $1697.0 in Q4 2025, and up 3905.96% YoY from $1661.0 in Q1 2025.
OSR Health (OSRHW) Other Non-Current Liabilities (2023 - 2026) Analysis & Trends
OSR Health has reported Other Non-Current Liabilities for 4 years, with the latest figure at $66539.0 in Q1 2026.
- Quarterly Other Non-Current Liabilities rose 3905.96% year-over-year to $66539.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $66539.0 (up 3905.96% YoY) and the FY2025 annual result came in at $1697.0, up 2.48% from the prior year.
- Other Non-Current Liabilities climbed to $66539.0 in Q1 2026 per OSRHW's latest filing, from $1697.0 in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $66539.0 in Q1 2026 and troughed at $1656.0 in Q4 2024.
- A 4-year average of $12869.3 and a median of $1737.0 in 2025 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2024 and 2026: Other Non-Current Liabilities plunged 88.96% in 2024, then surged 3905.96% in 2026.
- Over 4 years, Other Non-Current Liabilities stood at $15000.0 in 2023, then slumped by 88.96% to $1656.0 in 2024, then gained by 2.48% to $1697.0 in 2025, then jumped by 3820.98% to $66539.0 in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $66539.0, $1697.0, and $1737.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66,539.00 |
| Dec 31, 2025 | 1,697.00 |
| Sep 30, 2025 | 1,737.00 |
| Jun 30, 2025 | 1,795.00 |
| Mar 31, 2025 | 1,661.00 |
| Dec 31, 2024 | 1,656.00 |
| Dec 31, 2023 | 15,000.00 |